Evidence map›Paper›PMID 29866671›Full record

ArticleBMJ case reports2018

Treatment of extreme hypercalcaemia: the role of haemodialysis.

Anna B Basok, Boris Rogachev, Yosef Shmuel Haviv, Marina Vorobiov

Open access · hybridAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. [STEMI mimics : ST elevations on ECG: alternative diagnoses to acute coronary occlusion].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2023
    Review
  8. ISCCM Guidelines on Acute Kidney Injury and Renal Replacement Therapy.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2022
    Article
  9. Article
  10. A Review of Current Clinical Concepts in the Pathophysiology, Etiology, Diagnosis, and Management of Hypercalcemia.Medical science monitor : international medical journal of experimental and clinical research · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Anna B BasokDepartment of Nephrology, Soroka University Medical Center, Beer Sheva, Israel.
Boris RogachevDepartment of Nephrology, Soroka University Medical Center, Beer Sheva, Israel.
Yosef Shmuel HavivDepartment of Nephrology, Soroka University Medical Center, Beer Sheva, Israel.
Marina VorobiovDepartment of Nephrology, Soroka University Medical Center, Beer Sheva, Israel.
Soroka Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A patient with extremely high calcium level of 23.9 mg/dL (5.97 mmol/L) was admitted to our department unconscious with pathological ECG recording, demonstrating shortening of QT interval. The patient was treated by fluid resuscitation, bisphosphonates, salmon calcitonin and steroids. Haemodialysis with low calcium bath had been promptly provided with improvement of consciousness and calcium level. ECG changes disappeared. Subsequent investigations revealed hyperparathyroidism and a large parathyroid adenoma was then surgically removed. Extreme and rapid calcium elevation (parathyroid crisis) is rarely seen in primary hyperparathyroidism and usually is distinctive for malignancy. In the context of acute kidney injury and refractory hypercalcaemia with life-threatening complications (coma, ECG changes with impending danger of arrhythmia), haemodialysis may effectively decrease calcium levels. It should be pointed out that dialysis is an efficient method of treatment of refractory hypercalcaemia, parathyroid crisis, but it is rarely used due to its invasive nature.

Indexed as

AdenomaAgedBone Density Conservation AgentsCalcitoninDexamethasoneDiphosphonatesFluid TherapyGlucocorticoidsHumansHypercalcemiaMalePamidronateParathyroid NeoplasmsPrednisoneRenal DialysisSeverity of Illness IndexBone Density Conservation AgentsCalcitoninDexamethasoneDiphosphonatesGlucocorticoidsPamidronatePrednisonesalmon calcitoninacute renal failurearrhythmiascalcium and bonedialysisfluid electrolyte and acid-base disturbances

Identifiers

PMID29866671
PMCPMC5990060
OpenAlexW2805481739

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.